Gregory Karczmar to Neoplasm Transplantation
This is a "connection" page, showing publications Gregory Karczmar has written about Neoplasm Transplantation.
Connection Strength
0.959
-
New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med. 2004 Mar; 51(3):487-94.
Score: 0.219
-
X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors. Mol Imaging. 2015; 14.
Score: 0.116
-
Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors? Phys Med. 2010 Apr; 26(2):111-6.
Score: 0.080
-
Using high spectral and spatial resolution bold MRI to choose the optimal oxygenating treatment for individual cancer patients. Adv Exp Med Biol. 2003; 530:433-40.
Score: 0.050
-
Functional and anatomic imaging of tumor vasculature: high-resolution MR spectroscopic imaging combined with a superparamagnetic contrast agent. Acad Radiol. 2002 May; 9 Suppl 1:S115-8.
Score: 0.048
-
Spectrally inhomogeneous BOLD contrast changes detected in rodent tumors with high spectral and spatial resolution MRI. NMR Biomed. 2002 Feb; 15(1):28-36.
Score: 0.047
-
Differentiation of nonmetastatic and metastatic rodent prostate tumors with high spectral and spatial resolution MRI. Magn Reson Med. 2001 Jun; 45(6):1046-55.
Score: 0.045
-
MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys. 2000 May 01; 47(2):481-8.
Score: 0.042
-
A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging. 1998 Sep-Oct; 8(5):1126-34.
Score: 0.037
-
In vivo imaging of extraction fraction of low molecular weight MR contrast agents and perfusion rate in rodent tumors. Magn Reson Med. 1997 Aug; 38(2):259-68.
Score: 0.035
-
Spectroscopic imaging of the water resonance with short repetition time to study tumor response to hyperoxia. Magn Reson Med. 1997 Jul; 38(1):27-32.
Score: 0.034
-
Dynamic contrast measurements in rodent model tumors. Acad Radiol. 1996 Aug; 3 Suppl 2:S384-6.
Score: 0.032
-
Changes in T2*-weighted images during hyperoxia differentiate tumors from normal tissue. Magn Reson Med. 1995 Mar; 33(3):318-25.
Score: 0.029
-
Magnetic resonance measurement of response to hyperoxia differentiates tumors from normal tissue and may be sensitive to oxygen consumption. Invest Radiol. 1994 Jun; 29 Suppl 2:S161-3.
Score: 0.028
-
Effects of hyperoxia on T2* and resonance frequency weighted magnetic resonance images of rodent tumours. NMR Biomed. 1994 Mar; 7(1-2):3-11.
Score: 0.027
-
Magnetic resonance imaging of rodent tumors using radiofrequency gradient echoes. Magn Reson Imaging. 1994; 12(6):881-93.
Score: 0.027
-
The use of a reference tissue arterial input function with low-temporal-resolution DCE-MRI data. Phys Med Biol. 2010 Aug 21; 55(16):4871-83.
Score: 0.021
-
New vanadium-based magnetic resonance imaging probes: clinical potential for early detection of cancer. J Biol Inorg Chem. 2009 Nov; 14(8):1187-97.
Score: 0.020
-
Improvement of the rotating frame experiment by detection of residual Z magnetization: a 31P MRS study of metabolite levels in a Meth-A sarcoma. NMR Biomed. 1989 Apr; 1(4):159-64.
Score: 0.019